Attend as a delegate
Hear how pharma evaluates and manages partners, join the workshops and roundtables, and meet partners through pre-booked meetings.
Future Pharma Connect
Hyderabad, India
Pharma • CRO • CDMO • CMO Partnering Summit & Expo
Pharma and biotech buyers meet CROs, CDMOs, CRDMOs, CMOs and solution providers over two days of buyer-led sessions, a partnering expo, pre-booked one-to-one meetings and an awards evening.
The summit opens in
- –
- Days
- –
- Hours
- –
- Minutes
- –
- Seconds
- Dates
- 27 - 28 April 2027
- Timings
- Registration 09:00. Conference 10:00–17:00 on both days. Awards from 17:30 on 27 April.
- Location
- Hyderabad, India
Pharma outsourcing is changing
China+1 sourcing, the US BIOSECURE Act, growing biotech pipelines and demand for GLP-1s, peptides and biologics are changing how pharma companies choose, contract and manage their CRO, CDMO and CMO partners.
Results now depend on the partnership as much as on technical capability: choosing the right partner, structuring the right commercial model, moving molecules from research to commercial supply, staying inspection-ready across partners, and turning vendors into long-term alliances.
Over two days in Hyderabad, India's pharma capital, the summit follows the life of a partnership, from selection to governance.
- 01Selection
- 02Contracting
- 03Tech transfer
- 04Quality
- 05Capacity
- 06Governance
The Future Pharma Connect Expo runs alongside the conference. CROs, CDMOs, CMOs, API and peptide manufacturers, and laboratory and technology providers share one exhibition floor, with an open Expo Theatre and a B2B meeting lounge.
The sessions focus on what it takes to compete for, and deliver, the next wave of global pharma outsourcing.
Future Pharma Connect 2027 in numbers
- Attendees
- 1,000+
- Conference delegates
- 300+
- Expo visitors and hosted buyers
- 700+
- Exhibitors
- 25–30
- Speakers
- 60+
- Interactive sessions
- 30+
- Pre-booked B2B meetings
- 200+
- Expo pavilions
- 6
- Closed-door roundtables
- 6
- Days
- 2
- Future Pharma Connect Awards evening, from 17:30 on 27 April
Where pharma buyers meet their next partners
- 01Strategic business partnerships
- 02Buyer-led insights
- 03Practical partnership discussions
- 04China+1 opportunities
- 05Where the industry is heading by 2030
Future Pharma Connect puts the people who choose partners in the same room as the organisations that want to be chosen.
It's built for pharma and biotech companies, CROs, CDMOs, CMOs, API and peptide manufacturers, technology providers and life sciences startups. Come to hear buyer priorities, compare capabilities and start the right business conversations.
Future Pharma Connect is about better partnerships: helping both sides of the table turn insights into decisions and conversations into contracts.
Select. Structure. Deliver. Scale.
Eight themes across two days
Choosing the right partner
Evaluation, scorecards, RFPs and sourcing strategy
Commercial and contract models
Fee-for-service, FTE, risk-sharing, co-development and IP protection
China+1 and the BIOSECURE Act
Second sources, key starting materials and supply chain resilience
Molecule to market
Tech transfer, scale-up, CMC and integrated CRDMOs
Quality and inspection readiness
Quality agreements, partner audits and data integrity
Capacity for high-demand products
GLP-1s, peptides, sterile injectables, biologics and oligonucleotides
Partnership governance and performance
KPIs, joint steering committees and long-term alliances
Innovation and startups
AI drug discovery, clinical trial technology, smart manufacturing and investor partnerships
Four ways to take part
Exhibit at the expo
Take a stand at the Future Pharma Connect Expo and present your capabilities to pharma and biotech heads of outsourcing, external manufacturing, procurement and quality.
Sponsor the summit
Take one of only 8 conference speaking sessions, host a networking feature or support the awards.
Meet partners one to one
Use the B2B meeting lounge and Hosted Buyer Programme to meet pharma and biotech companies, CROs, CDMOs and CMOs looking for partners.
